retatrutide clinical trial doses Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) retatrutide dose study trial doses

Do not take a higher dose thinking it will "carry you through" the washout

At one point my coach says, You need to lose weight, Serena tells Womens Health

What makes retatrutide particularly noteworthy is its unique triple-agonist mechanism, which targets three different hormone receptor systems simultaneously rather than just one or two

IGF-1 (Insulin-like Growth Factor 1) Commonly associated with tissue repair and muscle development research

Insulin Sensitivity: Studies observed improvements in insulin resistance among adults with obesity

One analysis showed 9.4 percent of people on tirzepatide reported headache versus 7.5 percent on placebo, which makes it hard to pin the symptom directly on the drug